Related Experiment Video

Updated: May 15, 2026

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

[Mechanisms of resistance to target therapy]

Satoshi Matsusaka1

  • 1Department of Gastroenterology, Gastroenterology Center, The Cancer Institute Hospital.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|December 25, 2012
PubMed

Insights

Targeted cancer therapies offer fewer side effects but can face resistance. This review explores genetic mutations and signaling pathways that cause resistance to these advanced cancer treatments.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Cancer treatment is shifting from broad chemotherapy to targeted therapies.
  • Targeted agents aim to attack cancer cells specifically, minimizing harm to normal cells and reducing side effects.
  • Understanding resistance mechanisms is crucial for improving treatment efficacy.

Purpose of the Study:

  • To review the mechanisms of resistance to targeted cancer therapies.
  • To elucidate how genetic alterations and signaling pathway interactions contribute to treatment failure.
  • To explain the reproducible development of resistance in solid tumors.

Main Methods:

  • Literature review of existing research on targeted cancer therapy resistance.
  • Analysis of genetic resistance mechanisms, including secondary mutations.
  • Examination of bypass track resistance and signaling pathway cross-talk.
  • Discussion of defects in growth arrest and apoptosis pathways.

Main Results:

  • Secondary mutations can diminish the effectiveness of targeted therapies by affecting driver oncoproteins.
  • Cross-signaling between targeted receptors and other growth factor receptors contributes to resistance.
  • Solid tumors exhibit reproducible patterns in developing resistance to targeted agents.
  • Resistance can arise from genetic alterations, altered cellular signaling, and impaired cell death pathways.

Conclusions:

  • Resistance to targeted cancer therapy is a complex process involving multiple biological mechanisms.
  • Further research into these resistance pathways is essential for developing more effective and durable cancer treatments.
  • Overcoming resistance is key to maximizing the clinical benefit of targeted therapies.

More Related Videos

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...